In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next.

In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit http://Averna.com to learn more.

We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies.

To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup
• (00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter
• (00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4
• (00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall
• (00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies
• (00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna
• (00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular